formaldehyde has been researched along with Alloxan Diabetes in 47 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the effects of zonisamide on inflammatory and neuropathic pain using the mouse formalin test and streptozotocin (STZ)-induced diabetic mice with a reduced withdrawal threshold to mechanical stimuli, respectively." | 7.74 | Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy. ( Murakami, T; Ono, H; Tanabe, M, 2008) |
| "An excess of excitatory pathway activation via N-methyl-D-aspartate (NMDA) receptors has been described in neuropathic pain that responds poorly to morphine." | 7.71 | Magnesium increases morphine analgesic effect in different experimental models of pain. ( Begon, S; Dubray, C; Eschalier, A; Pickering, G, 2002) |
| "This study examined the effects of hyperglycemia and treatment with the aldose reductase inhibitor, Tolrestat, on the pain behavior evoked by injection of formalin into the dorsum of a single hind paw." | 7.69 | Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. ( Calcutt, NA; Malmberg, AB; Yaksh, TL; Yamamoto, T, 1994) |
| " Chronic administration of minocycline (40 and 80 mg/kg, i." | 5.37 | Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. ( Dua, K; Kulkarni, SK; Pabreja, K; Padi, SS; Sharma, S, 2011) |
| "Rats developed tactile allodynia within days of the onset of diabetes and which persisted for up to 8 weeks." | 5.29 | Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. ( Calcutt, NA; Chaplan, SR; Jorge, MC; Yaksh, TL, 1996) |
| "We evaluated the effects of zonisamide on inflammatory and neuropathic pain using the mouse formalin test and streptozotocin (STZ)-induced diabetic mice with a reduced withdrawal threshold to mechanical stimuli, respectively." | 3.74 | Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy. ( Murakami, T; Ono, H; Tanabe, M, 2008) |
| "An excess of excitatory pathway activation via N-methyl-D-aspartate (NMDA) receptors has been described in neuropathic pain that responds poorly to morphine." | 3.71 | Magnesium increases morphine analgesic effect in different experimental models of pain. ( Begon, S; Dubray, C; Eschalier, A; Pickering, G, 2002) |
| "This study examined the effects of hyperglycemia and treatment with the aldose reductase inhibitor, Tolrestat, on the pain behavior evoked by injection of formalin into the dorsum of a single hind paw." | 3.69 | Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats. ( Calcutt, NA; Malmberg, AB; Yaksh, TL; Yamamoto, T, 1994) |
| " Chronic administration of minocycline (40 and 80 mg/kg, i." | 1.37 | Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. ( Dua, K; Kulkarni, SK; Pabreja, K; Padi, SS; Sharma, S, 2011) |
| "Proglumide was ineffective by itself and it did not affect the antinociception induced by the cyclooxygenase inhibitors in non-diabetic rats." | 1.37 | Proglumide enhances the antinociceptive effect of cyclooxygenase inhibitors in diabetic rats in the formalin test. ( Aguilar-Mariscal, H; Bermúdez-Ocaña, DY; Blé-Castillo, JL; Díaz-Zagoya, JC; Flores-Murrieta, FJ; Frías, TR; Granados-Soto, V; Juárez-Rojop, IE, 2011) |
| "Neuropathic pain was induced by either ligation of left L5/L6 spinal nerves or administration of streptozotocin (50 mg/kg, i." | 1.33 | Benfotiamine relieves inflammatory and neuropathic pain in rats. ( Caram-Salas, NL; Granados-Soto, V; Medina-Santillán, R; Reyes-García, G; Rocha-González, HI; Sánchez-Ramírez, GM; Vidal-Cantú, GC, 2006) |
| ") significantly inhibited phenylquinone-evoked writhing movements in mice, but within this dose range no clear dose-response correlation was found." | 1.32 | Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia. ( Almási, R; Bölcskei, K; Börzsei, R; Elekes, K; Helyes, Z; Kéri, G; Petho, G; Pintér, E; Szabó, A; Szolcsányi, J; Szuts, T, 2004) |
| "Gabapentin displays efficacy against abnormal sensory processing in diabetic rats and may be of benefit for treating painful diabetic neuropathy." | 1.30 | Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. ( Calcutt, NA; Ceseña, RM, 1999) |
| " Following the chronic administration of methylamine, the urinary levels of both formaldehyde and malondialdehyde (a product from lipid peroxidation) are found to be substantially increased." | 1.30 | Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications. ( Deng, Y; Yu, PH, 1999) |
| "ICI 222155 also prevented hyperalgesia in diabetic rats 21-60 min after formalin, whereas tolrestat suppressed activity in diabetic rats below controls and also suppressed activity in controls when given orally or intrathecally." | 1.29 | Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. ( Calcutt, NA; Li, L; Malmberg, AB; Yaksh, TL, 1995) |
| " Chronic administration of methylamine enhances blood prorenin level, which strongly suggests that uncontrolled deamination of methylamine may be a risk factor for initiation of endothelial injury, and subsequent genesis of atherosclerosis." | 1.29 | Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. ( Yu, PH; Zuo, DM, 1996) |
| "Rats developed tactile allodynia within days of the onset of diabetes and which persisted for up to 8 weeks." | 1.29 | Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. ( Calcutt, NA; Chaplan, SR; Jorge, MC; Yaksh, TL, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.13) | 18.7374 |
| 1990's | 19 (40.43) | 18.2507 |
| 2000's | 16 (34.04) | 29.6817 |
| 2010's | 9 (19.15) | 24.3611 |
| 2020's | 2 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Li, J | 1 |
| Xu, L | 1 |
| Tan, D | 1 |
| Guo, R | 1 |
| Lin, W | 1 |
| Xu, H | 1 |
| Liu, Q | 1 |
| Song, X | 1 |
| Wang, C | 1 |
| Wang, X | 2 |
| Ma, S | 1 |
| Feng, Y | 1 |
| Meng, X | 1 |
| Liu, X | 1 |
| Wang, W | 1 |
| Lou, K | 1 |
| Roa-Coria, JE | 1 |
| Pineda-Farias, JB | 1 |
| Barragán-Iglesias, P | 1 |
| Quiñonez-Bastidas, GN | 1 |
| Zúñiga-Romero, Á | 1 |
| Huerta-Cruz, JC | 1 |
| Reyes-García, JG | 1 |
| Flores-Murrieta, FJ | 3 |
| Granados-Soto, V | 6 |
| Rocha-González, HI | 3 |
| García-Hernández, L | 1 |
| Navarrete-Vázquez, G | 1 |
| González-Trujano, ME | 1 |
| López-Muñoz, FJ | 1 |
| Déciga-Campos, M | 1 |
| Nacitarhan, C | 1 |
| Minareci, E | 1 |
| Sadan, G | 2 |
| Silva, M | 1 |
| Martins, D | 1 |
| Charrua, A | 1 |
| Piscitelli, F | 1 |
| Tavares, I | 1 |
| Morgado, C | 1 |
| Di Marzo, V | 1 |
| Huang, YH | 1 |
| Hou, SY | 1 |
| Cheng, JK | 1 |
| Wu, CH | 1 |
| Lin, CR | 1 |
| Tanabe, M | 1 |
| Murakami, T | 1 |
| Ono, H | 1 |
| Jolivalt, CG | 1 |
| Mizisin, LM | 1 |
| Nelson, A | 1 |
| Cunha, JM | 2 |
| Ramos, KM | 1 |
| Bonke, D | 1 |
| Calcutt, NA | 8 |
| Pabreja, K | 1 |
| Dua, K | 1 |
| Sharma, S | 1 |
| Padi, SS | 1 |
| Kulkarni, SK | 1 |
| Bermúdez-Ocaña, DY | 2 |
| Aguilar-Mariscal, H | 1 |
| Frías, TR | 1 |
| Blé-Castillo, JL | 1 |
| Díaz-Zagoya, JC | 2 |
| Juárez-Rojop, IE | 2 |
| Sazonova, OV | 1 |
| Trofimovich, EM | 1 |
| Koroshchenko, GA | 1 |
| Ageeva, TA | 1 |
| Aĭzman, RI | 1 |
| Subotialov, MA | 1 |
| Selivanova, SV | 1 |
| Schreiber, AK | 1 |
| Neufeld, M | 1 |
| Jesus, CH | 1 |
| Christianson, JA | 1 |
| Ryals, JM | 2 |
| McCarson, KE | 1 |
| Wright, DE | 2 |
| Tasatargil, A | 1 |
| Szolcsányi, J | 1 |
| Bölcskei, K | 1 |
| Szabó, A | 1 |
| Pintér, E | 1 |
| Petho, G | 1 |
| Elekes, K | 1 |
| Börzsei, R | 1 |
| Almási, R | 1 |
| Szuts, T | 1 |
| Kéri, G | 1 |
| Helyes, Z | 1 |
| Baluchnejadmojarad, T | 1 |
| Roghani, M | 1 |
| Roghani-Dehkordi, F | 1 |
| Araiza-Saldaña, CI | 2 |
| Reyes-García, G | 2 |
| Pérez-Severiano, F | 1 |
| Sánchez-Ramírez, GM | 1 |
| Caram-Salas, NL | 2 |
| Vidal-Cantú, GC | 1 |
| Medina-Santillán, R | 1 |
| Torres-López, JE | 1 |
| Ortíz-López, JU | 1 |
| Cruz-Vera, J | 1 |
| Johnson, MS | 1 |
| Arreola-Espino, R | 1 |
| Urquiza-Marín, H | 1 |
| Ambriz-Tututi, M | 1 |
| Mixcoatl-Zecuatl, T | 1 |
| Kamei, J | 7 |
| Hitosugi, H | 5 |
| Kasuya, Y | 2 |
| Malmberg, AB | 5 |
| Yamamoto, T | 1 |
| Yaksh, TL | 4 |
| Courteix, C | 1 |
| Eschalier, A | 2 |
| Lavarenne, J | 1 |
| Li, L | 1 |
| Yu, PH | 3 |
| Zuo, DM | 2 |
| Takeshita, N | 3 |
| Yamaguchi, I | 3 |
| Jorge, MC | 1 |
| Chaplan, SR | 1 |
| Kashiwazaki, T | 4 |
| Nagase, H | 3 |
| Ohsawa, M | 3 |
| Ceseña, RM | 1 |
| Taki, K | 2 |
| Crijns, FR | 1 |
| Wolffenbuttel, BH | 1 |
| De Mey, JG | 1 |
| Struijker Boudier, HA | 1 |
| Deng, Y | 1 |
| Stiller, C | 1 |
| Gustafsson, H | 1 |
| Kowaluk, EA | 1 |
| Mikusa, J | 1 |
| Wismer, CT | 1 |
| Zhu, CZ | 1 |
| Schweitzer, E | 1 |
| Lynch, JJ | 1 |
| Lee, CH | 1 |
| Jiang, M | 1 |
| Bhagwat, SS | 1 |
| Gomtsyan, A | 1 |
| McKie, J | 1 |
| Cox, BF | 1 |
| Polakowski, J | 1 |
| Reinhart, G | 1 |
| Williams, M | 1 |
| Jarvis, MF | 1 |
| Begon, S | 1 |
| Pickering, G | 1 |
| Dubray, C | 1 |
| Freshwater, JD | 1 |
| Svensson, CI | 1 |
| Kato, R | 1 |
| Gillette, JR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Magnesium Oral Supplementation to Reduce Pain in Patients With Severe Peripheral Arterial Occlusive Disease: The MAG-PAPER Randomized Clinical Trial[NCT02455726] | 150 participants (Anticipated) | Interventional | 2015-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
47 other studies available for formaldehyde and Alloxan Diabetes
| Article | Year |
|---|---|
A robust activatable two-photon fluorescent probe for endogenous formaldehyde biomarker visualization diagnosis and evaluation of diabetes mellitus.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Fluorescent Dyes; Formaldehyde; HeLa Cells; Hu | 2023 |
Fluorophore-Promoted Facile Deprotonation and Exocyclic Five-Membered Ring Cyclization for Selective and Dynamic Tracking of Labile Glyoxals.
Topics: Animals; Arginine; Chromatography, High Pressure Liquid; Cyclization; Diabetes Mellitus; Diabetes Me | 2020 |
Possible involvement of peripheral TRP channels in the hydrogen sulfide-induced hyperalgesia in diabetic rats.
Topics: Acetanilides; Analgesics; Animals; Capsaicin; Cystathionine beta-Synthase; Diabetes Mellitus, Experi | 2019 |
Antihyperalgesic activity of a novel synthesized analogue of lidocaine in diabetic rats.
Topics: Amines; Analgesics; Animals; Behavior, Animal; Cyclohexanecarboxylic Acids; Diabetes Complications; | 2013 |
The effect of benfotiamine on mu-opioid receptor mediated antinociception in experimental diabetes.
Topics: Analgesics; Analgesics, Opioid; Animals; Body Weight; Diabetes Mellitus, Experimental; Fentanyl; For | 2014 |
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Topics: Amides; Amidohydrolases; Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Capsaicin; Chronic Pa | 2016 |
Pulsed radiofrequency attenuates diabetic neuropathic pain and suppresses formalin-evoked spinal glutamate release in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Formaldehyde; Glutamic Acid; Male; | 2016 |
Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Formaldehyde; Inflammation; Isoxazo | 2008 |
B vitamins alleviate indices of neuropathic pain in diabetic rats.
Topics: Aldehydes; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Resp | 2009 |
Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Behavior, Animal; Biomarkers; Blood Glucose; Body W | 2011 |
Proglumide enhances the antinociceptive effect of cyclooxygenase inhibitors in diabetic rats in the formalin test.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cyclooxygenase Inhib | 2011 |
[To question about integrated prevention of diabetes taking into account the technogenic factors of environment (experimental results)].
Topics: Alloxan; Animals; Antioxidants; Curcuma; Diabetes Mellitus, Experimental; Drug Therapy, Combination; | 2012 |
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Topics: Analgesics; Animals; Arachidonic Acids; Behavior, Animal; Capsaicin; Diabetes Mellitus, Experimental | 2012 |
Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice.
Topics: Animals; Behavior, Animal; Blood Glucose; Body Weight; Cold Temperature; Diabetes Mellitus, Experime | 2003 |
Reduction in [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway.
Topics: Analgesics, Opioid; Animals; Arginine; Blood Glucose; Cyclic GMP; Diabetes Mellitus, Experimental; D | 2004 |
Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia.
Topics: Acute Disease; Analgesics; Animals; Behavior, Animal; Benzoquinones; Diabetes Mellitus, Experimental | 2004 |
Antinociceptive effect of Teucrium polium leaf extract in the diabetic rat formalin test.
Topics: Analgesics; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Formaldehyde; Male | 2005 |
Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Topics: Analgesia; Animals; Blood Glucose; Body Weight; Carbazoles; Cyclic GMP-Dependent Protein Kinases; Di | 2005 |
Benfotiamine relieves inflammatory and neuropathic pain in rats.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Diabetes Mellitus, Experimental; Dose-Respons | 2006 |
Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats.
Topics: Animals; Area Under Curve; Cholecystokinin; Diabetes Mellitus, Experimental; Dose-Response Relations | 2007 |
Diabetes-induced chemogenic hypoalgesia is paralleled by attenuated stimulus-induced fos expression in the spinal cord of diabetic mice.
Topics: Animals; Behavior, Animal; Cell Count; Diabetes Mellitus, Experimental; Disease Models, Animal; Form | 2007 |
Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Female; Formaldehyde; Guanid | 2007 |
Formalin-induced nociceptive responses in diabetic mice.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Dose-Response Relationship, | 1993 |
Effects of mexiletine on formalin-induced nociceptive responses in mice.
Topics: Animals; Diabetes Mellitus, Experimental; Formaldehyde; Injections, Intraperitoneal; Injections, Spi | 1993 |
Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats.
Topics: Aldehyde Reductase; Animals; Behavior, Animal; Body Weight; Diabetes Mellitus, Experimental; Female; | 1994 |
Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats.
Topics: Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Escape Reaction; Female; Formaldehyde; G | 1993 |
Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain.
Topics: Animals; Behavior, Animal; Blood Glucose; Chronic Disease; Diabetes Mellitus, Experimental; Disease | 1993 |
Different effects of two aldose reductase inhibitors on nociception and prostaglandin E.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Female; Formaldehyde; Hyperalgesia; In | 1995 |
Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury.
Topics: Allyl Compounds; Amine Oxidase (Copper-Containing); Animals; Butylamines; Deamination; Diabetes Mell | 1996 |
Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Formaldehyde; Indoles; Ketanser | 1995 |
Insulin attenuates formalin-induced nociceptive response in mice through a mechanism that is deranged by diabetes mellitus.
Topics: Analgesics; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Formaldehyde; Indoles; | 1997 |
Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine.
Topics: Aldehyde Reductase; Anesthetics, Local; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dia | 1996 |
The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relations | 1997 |
Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
Topics: Amine Oxidase (Copper-Containing); Animals; Aorta; Diabetes Mellitus, Experimental; Enzyme Inhibitor | 1997 |
Antinociceptive effects of morphine were different between experimental and genetic diabetes.
Topics: Analgesics, Opioid; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dopamine Agents; Do | 1998 |
Modulation of the formalin-induced nociceptive response by diabetes: possible involvement of protein kinase C.
Topics: Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Disease Models, Animal; Enzyme Activatio | 1998 |
Gabapentin prevents hyperalgesia during the formalin test in diabetic rats.
Topics: Acetates; Amines; Analgesics; Animals; Blood Glucose; Body Weight; Cyclohexanecarboxylic Acids; Diab | 1999 |
Algogenic mediator-induced nociceptive response in diabetic mice.
Topics: Animals; Benzylidene Compounds; Bradykinin; Diabetes Mellitus, Experimental; Dinoprost; Dose-Respons | 1999 |
Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
Topics: Animals; Capsaicin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; | 1999 |
Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Fixatives; Formaldehyde; Hy | 1999 |
Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications.
Topics: Amine Oxidase (Copper-Containing); Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, | 1999 |
Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Formaldehyde; Hindlimb; Hot Tempera | 2000 |
Modulation of the formalin-induced nociceptive response by diabetes: possible involvement of intracellular calcium.
Topics: Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disinfectants; Enzyme Inhi | 2000 |
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Topics: Adenosine Kinase; Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, | 2000 |
Magnesium increases morphine analgesic effect in different experimental models of pain.
Topics: Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Synergism; | 2002 |
Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Cyclooxygenase 1; Cycl | 2002 |
Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminopyrine; Aniline Compounds; Animals; Castration; Dia | 1965 |